Trial Profile
First- or Second-Line Subcutaneous Abatacept, Adalimumab, or Etanercept in patients with arthritis a comparison of Patient Characteristics, Healthcare Costs, and Biologic Persistence
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Aug 2015
Price :
$35
*
At a glance
- Drugs Abatacept (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 26 Aug 2015 New trial record